ClinConnect ClinConnect Logo
Search / Trial NCT04708808

The Effect of Music Therapy Under Ultrasound Guided Manual Vacuum Aspiration

Launched by CHINESE UNIVERSITY OF HONG KONG · Jan 12, 2021

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Music Termination Of Pregnancy Suction Curettage Evacuation Of Gestational Product Anxiety Abortion Pain Surgical Abortion Aspiration Abortion

ClinConnect Summary

This clinical trial is studying the effects of music therapy during a specific medical procedure called ultrasound-guided manual vacuum aspiration (USG-MVA), which is often used for early pregnancy loss. The aim is to see if listening to music can help reduce pain and anxiety for women undergoing this procedure. Participants will be divided into two groups: one will listen to music of their choice through Bluetooth headphones, while the other group will not have music. Researchers will measure pain and anxiety levels before, immediately after, and a couple of hours after the procedure to see if the music made a difference.

To be eligible for this study, women must be 18 years or older and admitted to the hospital for a first-trimester abortion using local anesthesia. However, those who are minors, have certain hearing impairments, or are taking specific medications for anxiety or pain before arriving at the hospital cannot participate. If you decide to join, you can expect a supportive environment where your comfort is a priority, and you'll have the chance to choose music that helps you feel relaxed during the procedure.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women 18 years old or above
  • hospitalized for termination of first trimester pregnancy under local anaesthesia
  • Exclusion Criteria:
  • being a minor or adult protected by law
  • not feasible for MVA procedure
  • Partial or total hearing impairment
  • on anxiolytics and analgesics before arriving at the hospital
  • refusal to participate

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Hong Kong, Shatin, Hong Kong

Patients applied

0 patients applied

Trial Officials

Pui Wah Jacqueline Chung, MBBS, PhD

Principal Investigator

Chinese University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials